INCRAFT覆膜支架腔内修复腹主动脉瘤的单中心应用经验  

Endovascular aortic repair of abdominal aorta aneurysm with INCRAFT endograft system:a single center experience

作　　者：薛冠华[1] 刘宇婷 杨硕菲[1] 陈佳佺[1] 郭相江[1] 倪其泓[1] 王韦仑 叶猛[1] 张岚[1] Xue Guanhua;Liu Yuting;Yang Shuofei;Chen Jiaquan;Guo Xiangjiang;Ni Qihong;Wang Weilun;Ye Meng;Zhang Lan(Department of Vascular Surgery,Renji Hospital,School of Medicine,Shanghai Jiao Tong University,Shanghai 200127,China)

机构地区：[1]上海交通大学医学院附属仁济医院血管外科,上海200127

出　　处：《中国血管外科杂志（电子版）》2021年第3期215-218,共4页Chinese Journal of Vascular Surgery(Electronic Version)

基　　金：国家自然科学基金面上项目(81873526)。

摘　　要：目的探讨INCRAFT覆膜支架腔内治疗腹主动脉瘤的临床效果。方法回顾性分析上海交通大学医学院附属仁济医院2018年1月至2020年10月应用INCRAFT覆膜支架腔内治疗的51例腹主动脉瘤患者临床资料,患者根据入路直径分为入路狭窄组(30例)和入路正常组(21例),比较两组术后内漏和再干预情况。结果技术成功率100%。患者术后随访215~1045 d,中位时间641d,均未发生髂支支架血栓及狭窄。入路狭窄组发生内漏3例(10.0%),其中Ⅱ型内漏2例,Ⅲ型内漏1例;入路正常组发生内漏2例(9.5%),其中Ⅱ型内漏1例,Ⅱ型合并Ⅲ型内漏1例,两组比较差异无统计学意义(χ2=0.178,P=0.673)。总再干预率为3.9%(2/51),两组均有1例行再干预,差异无统计学意义(χ2=0.225,P=0.635)。结论INCRAFT覆膜支架系统治疗包括入路困难在内的腹主动脉瘤,具有良好的安全性和有效性。Objective To investigate the clinical effect of endovascular aortic repair for abdominal aortic aneurysms with INCRAFT endograft system.Method The clinical data of 51 patients of abdominal aortic aneurysm treated with EVAR by INCRAFT endograft system from January 2018 to October 2020 in Renji Hospital,School of Medicine,Shanghai Jiao Tong University were analyzed retrospectively.They were divided into the stenosis group(30 cases)and the normal group(21 cases)according to the diameter of the approach.The postoperative endoleak and re-intervention between the two groups were compared.Result The technical success rate was 100%.The patients were followed up for 215~1045 days,with a median time of 641 days.There was no thrombosis and stenosis in iliac stent.Endoleak was found in 3 cases(10.0%)in the stenosis group,including 2 cases of typeⅡendoleak and 1 case of typeⅢendoleak,while 2 cases(9.5%)of the normal group had endoleak,including 1 case of typeⅡendoleak,1 case of typeⅡcombined with typeⅢendoleak.The difference between the two groups was not statistically significant(χ2=0.178,P=0.673).The total re-intervention rate was 3.9%(2/51).There was 1 case of re-intervention in each groups,and the difference was not statistically significant(χ2=0.225,P=0.635).Conclusion The INCRAFT endograft system can be used in endovascular aortic repair of abdominal aortic aneurysm including with difficult vessel access,with good safety and effectiveness.

关 键 词：腹主动脉瘤 支架 腔内修复 内漏 

分 类 号：R654.3[医药卫生—外科学]